Skip to content
GlobalBase

Zimbabwe Rejects ‘Lopsided’ American Health Aid Agreement Over Information Apprehensions

Medical aid illustration
The offered American funding would have supported initiatives for treating and preventing HIV/Aids, TB, and malaria.

The nation of Zimbabwe has declined a substantial American health deal worth $367m (272 million pounds) spanning five years due to Washington's demand for sensitive information.

This move was revealed following a government memo from December was disclosed, which showed President Emmerson Mnangagwa deemed the arrangement was "skewed".

A government representative later clarified that the US was requesting health data for research and profit but refused to guarantee the resulting advantages from any future medical innovations.

"We must now begin the difficult and regrettable process of ending our support in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont publicly.

The US Embassy indicated the United States had donated more than $1.9bn in health funding to Zimbabwe over the last twenty years.

A physicians' group in Zimbabwe has called for more dialogue to secure a deal agreeable to all parties so the country's critical HIV treatment initiative can proceed.

Broader Background

Zimbabwe's decision follows a similar situation in neighbouring Kenya, where a court suspended a similar deal with the US following legal challenges were filed about the security of Kenyans' health data.

Since returning to the presidency last year, US President Donald Trump has drastically cut overseas assistance and closed the US Agency for International Development (USAID).

The agency had overseen assistance for the US government, but Trump claimed its spending was "wasteful" and his government was seeking direct bilateral agreements to boost openness and responsibility.

As per reports, 16 African countries have so far signed similar agreements, constituting more than $18.3bn in committed funds.

Specifics of the Declined Agreement

The money for Zimbabwe was intended to supported "HIV/Aids treatment and prevention, TB, malaria, healthcare for mothers and children, and preparing for epidemics".

"We believe this partnership could have provided significant advantages for Zimbabwean communities, especially the 1.2 million men, women and children presently on antiretroviral therapy through US-supported programmes," the Ambassador said.

However, government spokesperson Nick Mangwana said the arrangement was "unequal".

"Our nation was requested to share its genetic material and health information over an extended period, without any corresponding promise of benefiting from any scientific breakthroughs – like new medicines or tests – that could result from that provided information," he stated.

"In essence, our nation would supply the basic resources for medical research without any certainty that the resulting innovations would be available to our population if a future disease outbreak arise."

National Interest and Global Health

Mangwana further pointed out that the American exit from the global health body and its push of bilateral deals were disrupting systems already set up via the global health agency.

Mangwana cited its Pathogen Access and Benefit Sharing scheme created to deal with future pandemics.

"This framework is designed to guarantee that when a country provides its samples, the benefits – such as medicines and cures – are distributed fairly, not commercialised solely by those with the resources to create them."

These objections over the US deal "must not be interpreted as opposition to America," Mangwana stressed.

"We encourage ongoing dialogue with our US partners on how subsequent co-operation could be structured in a manner that respects the independence and interests of each country."

Medical Community Reaction

A leading public health body expressed it acknowledged the government's concerns, but recommended that negotiations should continue given that a large portion of the country's Aids initiatives depended on foreign aid.

"In cases where specific concerns exist, such as those involving data governance or agreement terms, these can frequently be resolved through technical clarification and mutually agreed protections," it commented.

This impasse highlights the complex tensions between receiving crucial international aid and safeguarding local interests in an ever more data-driven world.

The writer

Michael Roberts

International business strategist with over 15 years of experience advising multinational corporations on market entry and expansion.

GlobalBase

Type to search articles.